Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

Pfizer Not Eligible To Recover $75 Million From Settlement With SEC

Judge ruled that Pfizer could not recover $75 million left over from insider trading SEC settlement.

International Business Times

The latest COVID booster will soon be available. Should I get one? Am I eligible?

Australia’s Therapeutic Goods Administration (TGA) has recently approved a new COVID booster. The shot was developed by Pfizer and targets the JN.1 sub-variant of Omicron.

The Conversation

ORIC: Working with Two Pharma Giants, Analysts See +100% Upside

ORIC Pharmaceuticals is a stock analyst price targets currently signal double-bagger potential in. See what the excitement around this firm is all about.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Thursday's Unusual Options Activity Reveals 3 Promising Long-Term Investments

Thursday's trading session revealed 33 call options with unusually high activity and boasting expiration dates of 365 days or more. Three have emerged as promising long-term investments from this diverse pool of potential opportunities.

Barchart

Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS

Pfizer stock and other vaccine shares tumbled Friday morning after Trump picked Kennedy to lead the Department of Health and Human Services.

Investors Business Daily

Amgen Drops 7% After A 'Big Unknown Risk' Rattles Its Monthly Obesity Shot

Amgen stock tumbled late Tuesday on a report its high-profile weight-loss shot, MariTide, could be linked to bone mineral density loss.

Investors Business Daily

Uber Among Top Profit Beats, But Apple Among The Worst

But Uber and Pfizer were among the 10 biggest beats vs. analyst estimates.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Reasons to be hopeful: five ways science is making the world better

If Trump’s re-election is getting you down, these innovations in medicine and technology should cheer you up

The Guardian - UK

Don't wait for a holiday surge. Now is a good time to get your flu and COVID-19 vaccines

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to spread

The Independent UK

Is This High-Yield Dividend Stock a Buy After Earnings?

This pharmaceutical giant's Q3 numbers came in ahead of Street estimates.

Barchart

Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO

Amgen is focusing deeply on its efforts to treat obesity, the CFO said Wednesday. Amgen stock rose early Thursday.

Investors Business Daily

Are Wall Street Analysts Predicting Pfizer Stock Will Climb or Sink?

Despite Pfizer’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Stock Market Today: Nasdaq Hits New High Ahead of Alphabet Earnings

The Google parent is one of several mega caps reporting earnings this week, with results due out after Tuesday's close.

Kiplinger

Why Pfizer Stock Is Lower After a Beat-and-Raise Quarter

Pfizer stock is down Tuesday even after the drugmaker reported higher-than-expected Q3 earnings and raised its full-year outlook.

Kiplinger

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Hundreds of blood cancer patients to benefit from new Pfizer treatment

Myeloma affects 24,000 people a year in the UK

Investors Business Daily

Dow Jones Falls Amid Key Data; Nvidia, Tesla Drop Below Buy Points

Stock Market Today: The Dow Jones industrials fell Tuesday amid key data. Nvidia stock and Tesla gave up buy points Monday.

Investors Business Daily

Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen.

Pfizer is taking on Amgen with its next steps in weight loss, the pharma titan said Tuesday as Pfizer stock dipped despite its beat.

Barchart

Stock Index Futures Tread Water Ahead of U.S. JOLTs Report, Alphabet Earnings on Tap

December S&P 500 E-Mini futures (ESZ24) are up +0.06%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.08% this morning as market participants geared up for the latest reading on U.S. job openings while also awaiting a deluge of corporate earnings reports from heavyweight names.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Gold price hits fresh record high, as bitcoin also rallies – as it happened

Analysts say gold is benefited from safe-haven demand amid persistent geopolitical tensions, expectations of monetary policy easing, and mounting uncertainty surrounding the US presidential election.

Fortune

As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch

Pfizer is getting back on track—but an even more potent prescription for success could be in the cards for the pharmaceutical giant under.

Investors Business Daily

Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises

Starboard took aim at Pfizer in another blow Tuesday, saying the company has failed to deliver on what it called the "best pipeline" ever.

Investors Business Daily

Nvidia Among Five Best S&P 500 Stocks Today

Pfizer spinoff Kenvue led the S&P 500 on Monday. Nvidia stock was close behind, breaking out to a record high.

Barchart

What to Expect From Pfizer's Q3 2024 Earnings Report

Pfizer is expected to release its fiscal third-quarter earnings later this month, and analysts project a triple-digit profit growth.

Barchart

Should You Follow Activist Investors Into This High-Yield Dividend Stock?

This dividend stock is now on the radar of activist investors, with Starboard eyeing a possible management shakeup.

The Guardian - UK

‘The UK is at the back of the race of turtles’: Sanofi’s boss on the need to develop new medicines

Paul Hudson, the Briton in charge of the French drug firm, is a big believer in the potential of AI to transform healthcare

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations